drugset

drugset / Trial / NCT03083821

A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting

NCT03083821 ↗

Phase 1 Completed 6 enrolled Bristol-Myers Squibb

NaSingle-groupOpen-labelTreatment

Summary

A Pharmacokinetics study of Baraclude in a real world clinical setting in Japan.

Timeline

Start: 2017-05-16
Primary completion: 2017-12-19
Completion: 2017-12-19

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Entecavir	Small molecule	—	—

Indications